Skip to main content
. 2012 Jan 8;30(10):1847–1854. doi: 10.1016/j.vaccine.2011.12.130

Table 2.

Distribution of anti-TT and anti-DT antibody titers before and 60 days after application of TCI formulation.

Anti-TT antibody titer
Anti-DT antibody titer
IU/mL Day 0* Day 60* IU/mL Day 0* Day 60*
<0.1 8 7 <0.1 1 1
0.1–1.0 15 9 0.1–1.0 17 8
1.0–5.0 4 9 1.0–2.0 7 12
5.0< 0 2 2.0< 2 6
Total 27 27 Total 27 27
Range <0.10–1.83 <0.10–6.47 Range <0.10–2.87 <0.10–6.15
Geometric mean 0.22 0.39 Geometric mean 0.56 1.06

Day 0 vs. 60, p < 0.01 in both anti-toxoids IgG titer by paired t-test.

*

Number of subjects.